ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China · Delayed Price · Currency is CNY

35.59

-1.01 (-2.76%)

Sep 4, 2026, 3:04 PM CST

Market Cap	15.96B -51.2%
Revenue (ttm)	840.19M -25.1%
Net Income	220.47M
EPS	0.49
Shares Out	448.53M
PE Ratio	72.92
Forward PE	30.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,607,336
Open	37.49
Previous Close	36.60
Day's Range	35.35 - 38.80
52-Week Range	29.31 - 76.88
Beta	0.77
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical C... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2002

Employees 1,294

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300723

Full Company Profile

Financial Performance

In 2025, SHE:300723's revenue was 932.27 million, a decrease of -35.72% compared to the previous year's 1.45 billion. Losses were -337.79 million, -37.45% less than in 2024.

Financial Statements